微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 3.09% | 36.12% | 72.63% | 85/160 | 4.14% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 1.79% | 203.39% | 24.31% | 88/160 | 2.6% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 1.44% | 94.59% | 137.99% | 75/160 | 2.3% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | -3.79% | -160.16% | -266.96% | 117/160 | -0.96% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 2.27% | -72.58% | 284.75% | 104/160 | 2.37% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 0.59% | -89.54% | -20.27% | 111/160 | 1.51% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 0.74% | -72.28% | -88.25% | 101/160 | 1.38% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 6.3% | 24.02% | -23.91% | 64/160 | 0.8% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 8.28% | 81.18% | 46.81% | 45/160 | 2.89% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 5.64% | 163.55% | 111.24% | 41/160 | 2.24% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 2.67% | 506.82% | -47.44% | 46/160 | 1.61% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 5.08% | -2.5% | 11.16% | 80/160 | 0.94% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | 4.57% | -33.38% | 113.55% | 83/160 | 4.53% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 2.14% | -59.24% | 386.36% | 96/160 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 0.44% | 41.94% | -91.55% | 105/160 | 2.52% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 5.21% | 17.61% | -24.05% | 84/160 | 3.74% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 6.86% | 54.16% | 30.67% | 60/160 | 3.22% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 5.25% | 272.34% | 1593.55% | 53/160 | 4.24% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | 0.31% | -27.91% | -93% | 84/160 | 2.24% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 4.43% | -60.23% | -0.45% | 92/160 | 2.78% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 4.45% | -57.21% | 215.6% | 74/160 | 7.61% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 1.41% | -79.68% | 227.91% | 95/160 | 5.05% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 0.43% | -87.05% | -96.14% | 96/160 | 2.46% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 11.14% | 19.02% | 7.12% | 45/160 | 7.09% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 10.4% | 5.26% | 49.86% | 24/160 | 7.26% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 6.94% | 45.49% | 109.04% | 26/160 | 4.65% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 3.32% | 61.95% | -64.53% | 24/160 | 2.55% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 9.36% | 163.66% | -5.26% | 55/160 | 9.66% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 9.88% | 123.02% | 107.13% | 31/160 | 8.31% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 4.77% | 136.14% | 132.68% | 48/160 | 5.59% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | 2.05% | 153.09% | -42.25% | 43/160 | 2.1% | 河化股份 | 54.24% | 行业排名> |
| 2016-12-31 | 3.55% | 11933.33% | -19.86% | 88/160 | 6.33% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 4.43% | 176.88% | 119.31% | 54/160 | 5.61% | 南新制药 | 81.7% | 行业排名> |
| 2016-06-30 | 2.02% | 461.11% | 149.38% | 69/160 | 3.53% | 德展健康 | 29.5% | 行业排名> |
| 2016-03-31 | 0.81% | 47.27% | 2800% | 61/160 | 2.65% | 贝达药业 | 16.78% | 行业排名> |
| 2015-12-31 | -0.03% | -101.83% | -101.88% | 94/160 | 11.35% | 河化股份 | 19.29% | 行业排名> |
| 2015-09-30 | 1.6% | -43.06% | 344.44% | 64/160 | 7.22% | 一品红 | 58.17% | 行业排名> |
| 2015-06-30 | 0.36% | -70% | -34.55% | 72/160 | 4.9% | 华东医药 | 36.97% | 行业排名> |
| 2015-03-31 | 0.55% | 223.53% | -66.46% | 59/160 | 2.41% | 华东医药 | 26.63% | 行业排名> |